Chicago, Illinois, September 17, 2003 – Substantial treatment costs and illness are suffered by end-stage kidney (renal) disease (ESRD) patients who develop Staph aureus blood stream infections ...
Hosted on MSN
Largest study of nose microbiome helps highlight those at risk of Staph aureus infection
People who persistently carry Staphylococcus aureus (S. aureus) in their nose have fewer species of other bacteria, while certain bacteria may help to prevent S. aureus colonization. These are the ...
Researchers at the University of Washington have uncovered how the bacterium Staphylococcus aureus, including the notorious MRSA (methicillin-resistant Staph aureus) “superbug” strains, resists our ...
As the threat of antibiotic resistance grows, a Swansea University academic has led the development of a novel technology capable of killing some of the most dangerous bacteria known to medicine—with ...
The multivalent toxoid vaccine made by LimmaTech Biologics, a Switzerland-based drug company, is designed to prevent skin and soft tissue infections caused by the bacterial pathogen. There are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback